WILLIAM D. SCHWIETERMAN, M.D. - Corporate Board Profile

Oncotelic Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-28	William D. Schwieterman, M.D. Age: 49 Director Since: 2007 Dr. Schwieterman has been an independent consultant to biotech and pharmaceutical companies specializing in clinical development since July 2002. ... During 2007, the Compensation Committee consisted of Messrs. Arthur B. Laffer (Chairman), William N. Shiebler and J. Richard Zecher. Effective in January 2008, Roy H. Fickling and William Schwieterman were added as members of the Compensation Committee. ... The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2007 to each of our directors. William D. Schwieterman Fees Earned or Paid in Cash: $17,583 Stock Awards: $163,600 Option Awards: $0 All Other Compensation: $0 Total: $181,183
2009-04-07	William D. Schwieterman, M.D. Age: 51 Director Since: 2007 Dr. Schwieterman has been an independent consultant to biotech and pharmaceutical companies specializing in clinical development since July 2002. Compensation Committee: During 2008, the Compensation Committee consisted of Messrs. Arthur B. Laffer (Chairman), Roy H. Fickling, William D. Schwieterman, M.D. William N. Shiebler and J. Richard Zecher. Science and Medical Committee: During 2008, the Science and Medical Committee consisted of Messrs. William D. Schwieterman, M.D. (Chairman), William N. Shiebler and J. Richard Zecher. Director Compensation: William D. Schwieterman received $37,875 in stock awards as director compensation in 2008.
2010-05-28	WILLIAM D. SCHWIETERMAN, M.D. Age: 51 Director Since: 2007 ... Dr. Schwieterman has been an independent consultant ... Compensation Committee consisted of Messrs. Arthur B. Laffer (Chairman), Roy H. Fickling, William D. Schwieterman, M.D. and William N. Shiebler ... Nominating and Governance Committee consists of William D. Schwieterman (Chairman), Tamar D. Howson and William N. Shiebler ... Director Compensation table shows William D. Schwieterman total compensation as $66,475.
2011-09-22	On April 27, 2010, Dr. Schwieterman (Chairman) and Ms. Howson were appointed to the Nominating and Governance Committee... Currently, the Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson and Mr. Shiebler... Director compensation table: William D. Schwieterman, $53,303 fees earned or stock awards.
2012-04-20	WILLIAM D. SCHWIETERMAN, M.D. Age: 54 Director Since: 2007 Principal Occupation: Dr. Schwieterman has been the Chief Medical Officer of Chelsea Therapeutics. ... Audit Committee consists of William D. Schwieterman, Tamar D. Howson and Gerald McMahon (Chairman). ... Compensation Committee consists of William D. Schwieterman, Tamar D. Howson (Chair) and Gerald McMahon. ... Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson and Dr. McMahon. ... Director Compensation Table shows William D. Schwieterman with total compensation of $45,796.
2013-06-13	The Audit Committee consists of William D. Schwieterman, Tamar D. Howson and Gerald McMahon (Chairman). ... The Compensation Committee consists of William D. Schwieterman, Tamar D. Howson (Chair) and Gerald McMahon. ... The Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson and Dr. McMahon. ... The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2012 to each of our non-employee directors. William D. Schwieterman: $80,000.
2014-04-30	Dr. Schwieterman was a member of the Audit Committee during 2013 and continued to serve on the Audit Committee until the appointment of Mr. Driscoll to the Audit Committee in February 2014. Dr. Schwieterman was a member of the Compensation Committee during 2013 and continued to serve on the Compensation Committee until the appointment of Mr. Driscoll to the Compensation Committee in February 2014. The Nominating and Governance Committee consists of Ms. Howson and Drs. Schwieterman (Chairman) and McMahon. The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2013 to each of our non-employee directors. William D. Schwieterman: $80,000.
2015-04-17	The Audit Committee consists of Mr. Driscoll (Chairman), Dr. McMahon, and Ms. Howson. Dr. Schwieterman was a member of the Audit Committee in fiscal year 2014 until the appointment of Mr. Driscoll to the Audit Committee in February 2014. During fiscal year 2014, the Audit Committee held five meetings. Our Audit Committee has the authority to retain and terminate the services of our independent registered public accounting firm, reviews our annual financial statements, considers matters relating to accounting policy and internal controls, and reviews the scope of our annual audits. The Board of Directors has adopted a charter for the Audit Committee, which is reviewed and reassessed annually by the Audit Committee. The Compensation Committee consists of Ms. Howson (Chairperson), Mr. Driscoll, and Dr. McMahon. During fiscal year 2014, the Compensation Committee held four meetings. Dr. Schwieterman was a member of the Compensation Committee in fiscal year 2014 until the appointment of Mr. Driscoll to the Compensation Committee in February 2014. Effective on the date of the Annual Meeting, Dr. Schwieterman will replace Dr. McMahon as a member of the Compensation Committee. The Compensation Committee's roles and responsibilities are set forth in the Compensation Committee's written charter, and include making recommendations to the Board of Directors regarding the compensation philosophy and compensation guidelines for our executives, the role and performance of our executive officers, and appropriate compensation levels for our CEO, which are determined without the CEO present, and other executives based on a comparative review of compensation practices of similarly situated businesses. The Compensation Committee also makes recommendations to the Board regarding the design and implementation of our compensation plans and the establishment of criteria and the approval of performance results relative to our incentive plans. The Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson, and Dr. McMahon. Effective on the date of the Annual Meeting, Dr. McMahon will replace Dr. Schwieterman as the Chairman of the Nominating and Governance Committee. All members of the Nominating and Governance Committee qualify as independent under the definition promulgated by The NASDAQ Stock Market. The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2014 to each of our non-employee directors. William D. Schwieterman: Fees Earned or Paid in Cash ($): 54,000; Stock Awards($): 0; Option Awards($): 0; All Other Compensation ($): 20,000; Total: 74,000. Dr. Schwieterman provides consulting services to us. The compensation reported in this column reflects payments for such consulting services rendered during fiscal year 2014. The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2014 to each of our non-employee directors. William D. Schwieterman: Fees Earned or Paid in Cash ($): 54,000; Stock Awards($): 0; Option Awards($): 0; All Other Compensation ($): 20,000; Total: 74,000.
2016-04-25	Since May 2015, Dr. Schwieterman has served as President and Chief Executive Officer of OXiGENE. Dr. Schwieterman was also compensated as a non-employee director prior to his appointment as President and Chief Executive Officer. The compensation Dr. Schwieterman received as a director prior to his appointment as President and Chief Executive Officer is included in the Summary Compensation Table.
2016-10-03	William D. Schwieterman, M.D. President and Chief Executive Officer
2017-04-26	Dr. Schwieterman has served as President and Chief Executive Officer since May 2015 and Chairman of the Board since August 18, 2016. Executive compensation table shows $866,312 total compensation for 2016.
2018-05-07	The following table sets forth certain information about each nominee. The ages of the nominees are as of March 30, 2018. William D. Schwieterman, M.D. Chairman of the Board of Directors, President and Chief Executive Officer. Summary Compensation Table shows William D. Schwieterman, M.D. total compensation in 2017 was $648,025.